Tag Archives: WDR

Biogen v. Mylan: When Does a Specification Fail to Describe a Newly-Presented Claim?

The disclosure requirements that will meet the written description requirement of s. 112(1) had a fairly mundane priority policing role prior to the expansion of the importance of the requirement in the biotech cases leading up to the en banc … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , | Leave a comment

Supreme Court Declines To Review “New And Improved” Written Description Requirement

On Tuesday, the Supreme Court denied Centocor’s (now “Janssen”) petition for cert. and so let stand a ruling that Centocor’s patents on humanized monoclonal antibodies (covering Abbott’s Humira) are invalid for failure to meet the written description requirement (WDR) of … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , , , , , , | Leave a comment

Top 2011 IP Stories on Patents4Life

I spent a day or two looking back over the breaking IP news that resulted in posts on Patents4Life. I wrote most of them, but want to take a pause to thank regular contributors Paul Cole, Ron Schutz and Stefan … Continue reading

Posted in Miscellaneous | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

BSC v. J & J – Written Description Requirement Spreads its Wings

On June 7th, in a Fed. Cir. panel decision written by Judge Moore, the panel affirmed the invalidation of four J&J patents (a copy of these patents is available at the end of this post) for failure to meet the … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , , , , , , , , , | 1 Comment